Trending Content - Investment Banking Forum
| +236 | UBS Healthcare | 49 | 1d |
| +72 | UBS MDs Treat Employees like Dogshit, Data to Prove it | 13 | 22m |
| +60 | Shana tova - happy new year | 12 | 1d |
| +58 | More diversity needed in the industry | 11 | 3d |
| +48 | NYC Wall Street Run Club | 13 | 3d |
| +45 | Lost all ambition / don’t care at all anymore | 19 | 2d |
| +39 | Coverage Banking is Paradise | 4 | 2h |
| +24 | What is the role of an analyst at your firm? | 3 | 1d |
| +23 | My Motivation Is At An All Time High | 3 | 14m |
| +22 | Feeling a bad pattern forming. I need some help | 3 | 5d |
Career Resources
Good point - This year can define a lot in the sector
Mergermarket
Rank HouseValue (EUR M) No. of Deals
1Morgan Stanley69,966
2Goldman Sachs & Co. LLC64,750
3Credit Suisse43,506
4Bank of America32,580
5JPMorgan31,629
6Rothschild & Co30,781
7Barclays27,358
8Citi22,128
9Evercore Inc.18,432
10Mediobanca S.p.A.13,080
Note that 31bn of this was driven by Aon Willis (GS,MS, CS advised; Mergermarket does not count BofA despite them getting a deal credit on Dealogic)
One stupid question - When you take into account the Aon Wililis Tower Watson deal, do CS + MS + GS add 30.5bn to their totals, or is it splitted between 3 (10.2bn each)?
Thanks again for your insightful information!
All three add 30bn
Can you please share the Healthcare ranking table. Thank you in advance
You could create another thread so people dont get confused and they can trace it
And any insights on ECM?
How does UBS / Barclays compare with GS/MS/JP/BofA when it comes to FIG? Do they have the same exit opps?
And is it GS FIG still the best team regarding exposure and exit opps in Europe?
Anyone could post how the league tables closed in 2020? Or does it remain the same as the one showed by Analyst 1?
FIG M&A, ECM or DCM?
Not a FIG guy at all, but from my understanding, it's hard to say who is the clear nr. 1/2/3 as each vertical is very different from each other (payments if even 100% under FIG, insurance, banks, asset managers and what not). It's a bit like categorising HC!
Maybe better if a FIG person comments, so take that with a grain of salt!
M&A
I know there are a lot of verticals but I was told that we will not cover a particular vertical during the first year, so wanted to understand how my team at UBS / Barc is positioned compared with the big US banks in terms of exits
Will throw what I think based on my experience, Interned in FIG so whilst I can't directly comment, I know people in the team I interned with (GS/MS/JPM/BofA) have in the past left for HF / PE - some generalist, some FIG Specific (JC Flowers or FIG focus teams at likes of Apollo, Blackstone etc.) . Will caveat that you will need to do more work on conventional finance if trying to be generalist as you don't really see EBITDA outside of Fintech, Insurance Brokerages or AM/WM.
GS FIG definitely has good exposure and I perceive it to have best exit opps too, but in terms of exits, your experience will matter more, with more M&A leaning towards better opps especially for PE.
Aliquid beatae nobis eos. Sint nemo consequatur nobis rerum sit.
Corporis et esse animi voluptas voluptas. Maiores odit sunt aut consequatur. Iste nihil quaerat eius laborum est ratione. Est perferendis porro nihil quo. Quia eos ut suscipit voluptatem. Repellendus ab dolor a tempora quae.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...